Xylo Technologies Ltd.
MDGS
Price:
$2.36
Market Cap:
$3.77M
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates on...[Read more]
Industry
Medical - Devices
IPO Date
2015-08-05
Stock Exchange
NASDAQ
Ticker
MDGS
PE Ratio
[-0.27]
ROE
[-29.00%]
Current Ratio
[1.14]
Dividend Yield
[0%]
Enterprise Value
[1.88M]
Dividend History
The ROE as of November 2025 (TTM) for Xylo Technologies Ltd. (MDGS) is -29.00%
According to Xylo Technologies Ltd.’s latest financial reports and current stock price. The company's current ROE is -29.00%. This represents a change of 64.92% compared to the average of -17.59% of the last 4 quarters.
Xylo Technologies Ltd. (MDGS) Historical ROE (quarterly & annually)
How has MDGS ROE performed in the past?
The mean historical ROE of Xylo Technologies Ltd. over the last ten years is -86.53%. The current -29.00% ROE has changed -66.48% with respect to the historical average. Over the past ten years (40 quarters), MDGS's ROE was at its highest in in the June 2021 quarter at 18.94%. The ROE was at its lowest in in the December 2019 quarter at -181.71%.
Average
-86.53%
Median
-46.18%
Minimum
-307.94%
Maximum
13.81%
Xylo Technologies Ltd. (MDGS) ROE by Quarter and Year
Discovering the peaks and valleys of Xylo Technologies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.06%
Maximum Annual ROE = 13.81%
Minimum Annual Increase = -281.56%
Minimum Annual ROE = -307.94%
| Year | ROE | Change |
|---|---|---|
| 2024 | -33.51% | -50.70% |
| 2023 | -67.97% | 171.06% |
| 2022 | -25.08% | -281.56% |
| 2021 | 13.81% | -173.33% |
| 2020 | -18.84% | -91.09% |
| 2019 | -211.39% | 158.84% |
| 2018 | -81.67% | 76.85% |
| 2017 | -46.18% | -85.00% |
Xylo Technologies Ltd. (MDGS) Average ROE
How has MDGS ROE performed in the past?
The current ROE of Xylo Technologies Ltd. (MDGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-42.19%
5-year avg
-26.32%
10-year avg
-86.53%
Xylo Technologies Ltd. (MDGS) ROE vs. Peers
How is MDGS’s ROE compared to its peers?
Xylo Technologies Ltd.’s ROE is greater than ViewRay, Inc. (-85.33%), less than Ra Medical Systems, Inc. (451.17%), greater than Holdco Nuvo Group D.G Ltd. Ordinary Shares (-36.55%), less than Mallinckrodt plc (10.92%), greater than TNF Pharmaceuticals, Inc. (-48.34%), greater than Nabriva Therapeutics plc (-201.91%), greater than Hillstream BioPharma, Inc. (-1397.15%), less than Aptose Biosciences Inc. (123.88%), less than Gamida Cell Ltd. (1.15%), greater than Pear Therapeutics, Inc. (-39.23%),
| Company | ROE | Market cap |
|---|---|---|
| -85.33% | $4.56M | |
| 451.17% | $3.84M | |
| -36.55% | $5.65M | |
| 10.92% | $4.52M | |
| -48.34% | $9.18M | |
| -201.91% | $323.00 | |
| -1397.15% | $4.17M | |
| 123.88% | $4.36M | |
| 1.15% | $4.34M | |
| -39.23% | $4.09M |
Build a custom stock screener for Xylo Technologies Ltd. (MDGS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xylo Technologies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Xylo Technologies Ltd. (MDGS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Xylo Technologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Xylo Technologies Ltd.'s ROE?
How is the ROE calculated for Xylo Technologies Ltd. (MDGS)?
What is the highest ROE for Xylo Technologies Ltd. (MDGS)?
What is the 3-year average ROE for Xylo Technologies Ltd. (MDGS)?
What is the 5-year average ROE for Xylo Technologies Ltd. (MDGS)?
How does the current ROE for Xylo Technologies Ltd. (MDGS) compare to its historical average?